These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10681316)

  • 1. A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies.
    Machard S; Theodoro F; Benech H; Grognet JM; Ezan E
    Antimicrob Agents Chemother; 2000 Mar; 44(3):546-50. PubMed ID: 10681316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B.
    Koizumi T; Kubo K; Kaneki T; Hanaoka M; Hayano T; Miyahara T; Okada K; Fujimoto K; Yamamoto H; Kobayashi T; Sekiguchi M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1597-600. PubMed ID: 9660990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3719-23. PubMed ID: 12435667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of amphotericin B in serum and tissues in mice treated with amphotericin B-Intralipid.
    Shadkchan Y; Zaslavsky Z; Segal E
    Med Mycol; 2003 Feb; 41(1):15-9. PubMed ID: 12627800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissue distribution studies.
    Wang LH; Smith PC; Anderson KL; Fielding RM
    J Chromatogr; 1992 Sep; 579(2):259-68. PubMed ID: 1429973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.
    Groll AH; Mickiene D; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2000 Feb; 44(2):408-10. PubMed ID: 10639371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
    Usman F; Nopparat J; Javed I; Srichana T
    Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary extraction and accumulation of lipid formulations of amphotericin B.
    Matot I; Pizov R
    Crit Care Med; 2000 Jul; 28(7):2528-32. PubMed ID: 10921589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of amphotericin B when delivered through cholesterol hemisuccinate vesicles in normal and A. fumigatus infected mice.
    Saxena S; Ghosh PC
    Pharm Res; 2000 Oct; 17(10):1236-42. PubMed ID: 11145229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay.
    Al-Quadeib BT; Radwan MA; Siller L; Mutch E; Horrocks B; Wright M; Alshaer A
    Biomed Chromatogr; 2014 Dec; 28(12):1652-9. PubMed ID: 24733605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition.
    Kagan L; Gershkovich P; Wasan KM; Mager DE
    Pharm Res; 2014 Jan; 31(1):35-45. PubMed ID: 23793994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.
    van Etten EW; Otte-Lambillion M; van Vianen W; ten Kate MT; Bakker-Woudenberg AJ
    J Antimicrob Chemother; 1995 Apr; 35(4):509-19. PubMed ID: 7628985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and Fungizone after repeated dosing in rats.
    Wang LH; Fielding RM; Smith PC; Guo LS
    Pharm Res; 1995 Feb; 12(2):275-83. PubMed ID: 7784345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel delivery system for amphotericin B with lipid nano-sphere (LNS).
    Fukui H; Koike T; Saheki A; Sonoke S; Seki J
    Int J Pharm; 2003 Oct; 265(1-2):37-45. PubMed ID: 14522116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection.
    Kaur K; Kumar P; Kush P
    Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.